TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer
scientific article published on 5 February 2017
Author/s
author: Hermann Brenner, Alison Dunning, Veli-Matti Kosma, Kyriaki Michailidou, Arto Mannermaa, Georgia Chenevix-Trench, Kristiina Aittomäki, Montserrat García-Closas, Kamila Czene, Jenny Chang-Claude, Jonathan Beesley, Jani Saarela, Giuseppe Floris, Marjanka K Schmidt, Melissa C. Southey, Paul D P Pharoah, Sofia Khan, Per Hall, Diether Lambrechts, Heli Nevanlinna, Douglas F. Easton, Fergus J. Couch, Peter A. Fasching, John Hopper, Ute Hamann, Annika Lindblom, Irene L Andrulis, Jonine Figueroa, Sara Margolin, Joe Dennis, Carl Blomqvist, Gord Glendon, Maartje J. Hooning, Jianjun Liu, Bernd Holleczek, Michael J Lush, Rainer Fagerholm, Päivi Heikkilä, Manjeet K Bolla, Agnes Jager, Mitul Shah, Maria Kabisch, Fiona M Blows, Maral Jamshidi, Sabine Behrens, Emily Hallberg, kConFab Investigators, Renske Keeman, Elena Provenzano
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.